FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109092008> ?p ?o ?g. }

• W2109092008 endingPage "514" @default.
• W2109092008 startingPage "497" @default.
• W2109092008 abstract "Being mediators of immune and inflammatory reactions, abnormal or excessive production of cytokines is often the main cause of the pathology in many types of disease. Targeting cytokines by means of inhibitory drugs may thus offer a valid therapeutic approach in particular diseases. Soluble forms of cytokine receptors (sCR) normally participate in the control of cytokine activity in vivo by inhibiting the ability of cytokines to bind their membrane receptors and from generating a biological response. The ability of sCR to act as cytokine inhibitors, coupled to their specificity, high affinities and low immunogenicities have prompted considerable interest in their use as immunotherapeutic agents. In fact, many types of sCR have been shown to inhibit the biological activity of their cytokines in vitro and in different experimental models. Several sCR, particularly the soluble TNF receptors sTNFR-I (p55) and sTNFR-II (p75), have been modified by linking them to the Fc portion of human immunoglobulin (e.g., 'immunoadhesins') or by the addition of polyethylene-glycol (PEG) (e.g., 'PEGylation'), in order to enhance their affinity and/or biological half-life. These agents have shown significant therapeutic value in clinical trials of patients with rheumatoid arthritis (RA). Indeed, a sTNFR-II:Fc hybrid molecule (etanercept), the first sCR-derived therapeutic agent to receive approval for human use, is already utilised for the treatment of some forms of RA. Additional applications of this drug in other inflammatory conditions are currently being evaluated, while another sCR-derived agent, a human sIL-4R, is undergoing trials for the treatment of asthma. Many other sCR, such as sIL-1R, sIL-5R, sIFNgammaR, may also have significant potential for the treatment of a wide variety of human diseases." @default.
• W2109092008 created "2016-06-24" @default.
• W2109092008 creator A5032077494 @default.
• W2109092008 date "2000-03-01" @default.
• W2109092008 modified "2023-10-17" @default.
• W2109092008 title "Soluble cytokine receptors: novel immunotherapeutic agents" @default.
• W2109092008 cites W1527168089 @default.
• W2109092008 cites W1556064830 @default.
• W2109092008 cites W1580250276 @default.
• W2109092008 cites W1917885463 @default.
• W2109092008 cites W1933900219 @default.
• W2109092008 cites W1936203546 @default.
• W2109092008 cites W1964033932 @default.
• W2109092008 cites W1964347128 @default.
• W2109092008 cites W1964713808 @default.
• W2109092008 cites W1964899306 @default.
• W2109092008 cites W1967413976 @default.
• W2109092008 cites W1973312385 @default.
• W2109092008 cites W1974603163 @default.
• W2109092008 cites W1977151756 @default.
• W2109092008 cites W1978417778 @default.
• W2109092008 cites W1988567136 @default.
• W2109092008 cites W1993685370 @default.
• W2109092008 cites W1997318094 @default.
• W2109092008 cites W2002507218 @default.
• W2109092008 cites W2008787181 @default.
• W2109092008 cites W2012467309 @default.
• W2109092008 cites W2017228357 @default.
• W2109092008 cites W2028751330 @default.
• W2109092008 cites W2029093574 @default.
• W2109092008 cites W2033734753 @default.
• W2109092008 cites W2040397111 @default.
• W2109092008 cites W2044673785 @default.
• W2109092008 cites W2045403629 @default.
• W2109092008 cites W2053212420 @default.
• W2109092008 cites W2054904907 @default.
• W2109092008 cites W2062784484 @default.
• W2109092008 cites W2085050817 @default.
• W2109092008 cites W2087831434 @default.
• W2109092008 cites W2094557312 @default.
• W2109092008 cites W2096824527 @default.
• W2109092008 cites W2097520274 @default.
• W2109092008 cites W2098767548 @default.
• W2109092008 cites W2106216921 @default.
• W2109092008 cites W2108473659 @default.
• W2109092008 cites W2108491756 @default.
• W2109092008 cites W2119120508 @default.
• W2109092008 cites W2125499492 @default.
• W2109092008 cites W2132562760 @default.
• W2109092008 cites W2134818464 @default.
• W2109092008 cites W2135757997 @default.
• W2109092008 cites W2153011776 @default.
• W2109092008 cites W2153398168 @default.
• W2109092008 cites W2156016155 @default.
• W2109092008 cites W2157455033 @default.
• W2109092008 cites W2172413152 @default.
• W2109092008 cites W2175994433 @default.
• W2109092008 cites W2270283907 @default.
• W2109092008 cites W2314052274 @default.
• W2109092008 cites W2328587823 @default.
• W2109092008 cites W4243344273 @default.
• W2109092008 cites W4244158828 @default.
• W2109092008 doi "https://doi.org/10.1517/13543784.9.3.497" @default.
• W2109092008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11060691" @default.
• W2109092008 hasPublicationYear "2000" @default.
• W2109092008 type Work @default.
• W2109092008 sameAs 2109092008 @default.
• W2109092008 citedByCount "52" @default.
• W2109092008 countsByYear W21090920082012 @default.
• W2109092008 countsByYear W21090920082013 @default.
• W2109092008 countsByYear W21090920082014 @default.
• W2109092008 countsByYear W21090920082015 @default.
• W2109092008 countsByYear W21090920082016 @default.
• W2109092008 countsByYear W21090920082019 @default.
• W2109092008 countsByYear W21090920082020 @default.
• W2109092008 countsByYear W21090920082021 @default.
• W2109092008 crossrefType "journal-article" @default.
• W2109092008 hasAuthorship W2109092008A5032077494 @default.
• W2109092008 hasConcept C150903083 @default.
• W2109092008 hasConcept C170493617 @default.
• W2109092008 hasConcept C17991360 @default.
• W2109092008 hasConcept C185592680 @default.
• W2109092008 hasConcept C203014093 @default.
• W2109092008 hasConcept C207001950 @default.
• W2109092008 hasConcept C2777226972 @default.
• W2109092008 hasConcept C2777575956 @default.
• W2109092008 hasConcept C2778690821 @default.
• W2109092008 hasConcept C2779149719 @default.
• W2109092008 hasConcept C55493867 @default.
• W2109092008 hasConcept C71924100 @default.
• W2109092008 hasConcept C86803240 @default.
• W2109092008 hasConcept C8891405 @default.
• W2109092008 hasConcept C98274493 @default.
• W2109092008 hasConceptScore W2109092008C150903083 @default.
• W2109092008 hasConceptScore W2109092008C170493617 @default.
• W2109092008 hasConceptScore W2109092008C17991360 @default.
• W2109092008 hasConceptScore W2109092008C185592680 @default.
• W2109092008 hasConceptScore W2109092008C203014093 @default.

• next